Table 3.

Univariate survival analysis

Variable	HR*	95% Confidence Interval	P
Age	2.13	1.38–3.28	.001*
Sex	1.03	0.67–1.59	.90
KPS (median)	3.87	2.43–6.15	<.001*
Treatmenta	8.41	4.99–14.16	<.001*
hTERT mRNA expression	1.90	1.23–2.96	.004*
TA	1.78	1.14–2.76	.011*
Telomere length	0.70	0.45–1.09	.11
MGMT promoter methylation	1.27	0.81–1.99	.30
IDH1 mutation status	4.59	1.43–14.64	.010*

*Hazard ratio (HR) for death.

^aTreatment grouped according to surgery only vs surgery plus subsequent therapy.